SCHEMBL26039316

SCHEMBL26039316

CCc1cc2c(s1)CCO[C@@]21CCN(CCO)[C@@H](C)C1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26039578 0.94 — —
SCHEMBL26039645 0.89 SIGMAR1 (0.33) SIGMAR1
SCHEMBL25354788 0.88 OPRM1 (0.33) —
SCHEMBL26058045 0.87 SIGMAR1 (0.33) SIGMAR1
SCHEMBL26041399 0.87 SIGMAR1 (0.33) SIGMAR1
SCHEMBL26039572 0.87 OPRD1 (0.30) —
SCHEMBL26039574 0.85 SIGMAR1 (0.33) SIGMAR1
SCHEMBL26039381 0.85 OPRL1 (0.31) —
SCHEMBL26039260 0.85 OPRL1 (0.31) —
SCHEMBL26039259 0.85 OPRM1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 — — WO disclosed
Send feedback